Exagen inc. to participate in the 2024 cantor global healthcare conference

Carlsbad, calif., sept. 04, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the 2024 cantor global healthcare conference, which takes place september 17-19, 2024, at the intercontinental barclay hotel in new york city. john aballi, exagen's president and chief executive officer and jeff black, exagen's chief financial officer, will participate in a fireside chat on wednesday, september 18th, at 9:45 am et.
XGN Ratings Summary
XGN Quant Ranking